NanoViricides (NNVC) Narrows Q1 Loss

NanoViricides (NYSE: NNVC) reported Q1 EPS of $0.00, versus ($0.04) reported last year. Loss from operations narrower from $1.89 million down to $1.69 million.

For earnings history and earnings-related data on NanoViricides (NNVC) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Rochon family buys $100M in AIAI Holdings shares at $20 each
• Pfizer reafffirms 2026 guidance after CFO transition announcement